High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects
Huawei Tong, Jia Huang(Chinese Academy of Sciences), Qingquan Xiao(Chinese Academy of Sciences), Bingbing He(Chinese Academy of Sciences), Xue Dong(Chinese Academy of Sciences), Yuanhua Liu(Chinese Academy of Sciences), Xiali Yang(Fujian Medical University), Dingyi Han(Chinese Academy of Sciences), Zikang Wang(Chinese Academy of Sciences), Xuchen Wang(Chinese Academy of Sciences), Wenqin Ying(Chinese Academy of Sciences), Runze Zhang(Chinese Academy of Sciences), Wei Yu(Chinese Academy of Sciences), Chunlong Xu(Chinese Academy of Sciences), Yingsi Zhou(Chinese Academy of Sciences), Yanfei Li(Shanghai Medical College of Fudan University), Minqing Cai(Chinese Academy of Sciences), Qifang Wang(Chinese Academy of Sciences), Mingxing Xue(Chinese Academy of Sciences), Guoling Li(Chinese Academy of Sciences), Kailun Fang(Chinese Academy of Sciences), Hainan Zhang(Chinese Academy of Sciences), Hui Yang(Center for Excellence in Brain Science and Intelligence Technology)
Cited by 217